Most men with small abdominal aortic aneurysms, 3.0 cm to 5.4 cm, could be safely monitored with ultrasound at longer intervals.
Most men with small abdominal aortic aneurysms (3.0 cm to 5.4 cm) could be safely monitored with ultrasound at longer intervals than they are currently, say researchers in a Journal of the American Medical Association study.
Researchers from the University of Cambridge in the UK investigated the time intervals for ultrasound surveillance of AAAs to optimize the intervals with minimal risk of aneurysm rupture. Safe longer times between ultrasound scans may result in lower healthcare costs and increased patient convenience.
The meta-analysis of current AAA screening programs involved a systemic literature search through December 2010. The researchers analyzed the AAA diameters using a random-effects model. Rupture rates were analyzed by proportional hazards regression using the modeled AAA diameter as a time-varying covariate. Predictions of risks exceeding 5.5 cm in diameter and of rupture within given time intervals were estimated and pooled across studies by random effects met-analysis.
Data from repeated ultrasound measurements of AAA diameter among 15,471 patients showed that growth of the AAAs and their rupture rates varied widely across the 18 studies. On average, for each 0.5-cm increase in AAA diameter, growth rates increased on average by 0.59 mm per year. Rupture rates increased by a factor of 1.91.
The researchers determined that to control AAA growth risk in men of exceeding 5.5 cm to below 10 percent, on average, a 7.4-year surveillance interval is sufficient for a 3.0-cm AAA, while an 8-month interval would be needed for a larger, 5.0-cm AAA.
“To control the risk of rupture in men to below 1 percent, the corresponding estimated surveillance intervals are 8.5 years and 17 months,” wrote the authors.
The authors pointed out that these findings do not translate to women. During the study, it was noted that there were 178 ruptures among 11,262 men and 50 among 1,214 women.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.